Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method

Journal of Pharmaceutical Sciences

Volumn 91, Issue 9, 2002, Pages 1948-1957

  Sethia, Sundeep ^a   Squillante, Emilio ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

Caco 2; Carbamazepine; Coprecipitates; Gelucire 44 14; PEG 8000; Polymorphism; SEDS; Solid dispersions; Supercritical fluid; TPGS

Indexed keywords

ALPHA TOCOPHEROL SUCCINATE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBON DIOXIDE; GELUCIRE; MACROGOL 8000; SOLVENT;

ARTICLE; CELL STRAIN CACO 2; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG SOLUBILITY; HUMAN; HUMAN CELL; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; SOLID; SUPERCRITICAL FLUID; X RAY POWDER DIFFRACTION;

EID: 0036771080     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10186     Document Type: Article

References (26)

1. Sekiguchi K, Obi N, Ueda Y. 1964. Studies on absorption of eutectic mixtures. II. Absorption of fused conglomerates of chloramphenicol and urea in rabbits. Chem Pharm Bull 12:134-144.
2. Chiou WL, Niazi S. 1971. Phase diagram and dissolution-rate studies on sulfathiazole-urea solid dispersions. J Pharm Sci 60:1333-1338.
3. Allen DJ, Kwan KC. 1969. Determination of the degree of crystallinity in solid-solid equilibria. J Pharm Sci 58:1190-1193.
4. Ford JL, Rubinstein MH. 1978. Phase equilibria and dissolution rates of indomethacin-polyethylene glycol 6000 solid dispersions. Pharm Acta Helv 53:327-332.
5. Chiou WL, Riegelman S. 1971. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60:1281-1302.
6. Sekiguchi K, Obi N. 1961. Studies on absorption of eutectic mixtures. I. A comparison of the behavior of eutectic mixtures of sulphathiazole and that of ordinary sulphathiazole in man. Chem Pharm Bull 9:866-872.
7. Tachibana T, Nakamura A. 1965. A method for preparing an aqueous colloidal dispersion of organic materials by using water-soluble polymers: Dispersion of beta-carotene by polyvinylpyrrolidone. Kolloid-Z Polym 203:130-133.
8. 2. Int J Pharm 148:123-130.
9. Kerc J, Srcic S, Knez Z, Sencar-Bozic P. 1999. Micronization of drugs using supercritical carbon dioxide. Int J Pharm 182:33-39.
10. Gallagher PM, Coffey MP, Krukonis VJ, Klasutis N. 1989. Gas antisolvent recrystallization: A new process to recrystallize compounds in supercritical fluids. Am Chem Soc Symp Ser 406:334-354.
11. Serajuddin ATM. 1999. Solid dispersions of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 88:1058-1066.
12. Khoo SM, Porter CJH, Charman WN. 2000. The formulation of halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions: Physical stability and absolute bioavailability assessment. Int J Pharm 205:65-78.
13. Kahela P, Aaltonen R, Lewing E, Antilla M, Kristoffersson E. 1983. Pharmacokinetics and dissolution of two crystalline forms of carbamazepine. Int J Pharm 14:103-112.
14. Bertillson L. 1978. Clinical pharmacokinetics of carbamazepine. Clin Pharmacokinet 3:128-143.
15. Higuchi T, Connors KA. 1965. Phase-solubility techniques. Adv Anal Chem Instr 4:117-210.
16. Hilgers AR, Conradi RA, Burton PS. 1990. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res 7:902-910.
17. Cory AH, Owen TC, Barltrop JA, Cory JG. 1991. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in culture. Cancer Commun 3:207-212.
18. Mura P, Manderioli A, Bramanti G, Ceccarelli L. 1996. Properties of solid dispersions of naproxen in various polyethylene glycols. Drug Dev Ind Pharm 22:909-916.
19. Dordunoo SK, Ford JL, Rubinstein MH. 1991. Preformulation studies on solid dispersions containing triamterene or temazepam in polyethylene glycols or Gelucire 44/14 for liquid filling of hard gelatin capsules. Drug Dev Ind Pharm 17:1685-1713.
20. Krahn FU, Mielck JB. 1987. Relations between several polymorphic forms and the dihydrate of carbamazepine. Pharm Acta Helv 67:247-254.
21. Lowes MMJ, Caira MR, Lotter AP, Van Der Watt JG. 1987. Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine. J Pharm Sci 76:744-752.
22. Rustichelli C, Gamberini G, Ferioli V, Gamberini MC, Ficarra R, Tommasini S. 2000. Solid-state study of polymorphic drugs: Carbamazepine. J Pharm Biomed Anal 23:41-54.
23. Craig DQM, Newton JM. 1991. Characterisation of polyethylene glycols using differential scanning calorimetry. Int J Pharm 74:33-41.
24. Sheu MT, Yeh CM, Sokolowski TD. 1994. Characterization and dissolution of fenofibrate solid dispersion systems. Int J Pharm 103:137-146.
25. Van den Mooter G, Augustijns P, Blaton N, Kinget R. 1998. Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm 164:67-80.
26. Harris JM. 1992. Poly(ethylene glycol) chemistry: Biotechnical and biomedical applications; New York: Plenum Press. pp 1-14.